Similarly, the upregulated mRNA expression levels of M1 macrophages (Cd86) and M2 macrophages (Mrc1) in the BLM model were significantly reduced by MSCs, regardless of the route of administration (Fig. 6D). This evidence concerns the gene CD86 and Bloom syndrome.